Tenet Healthcare Corporation New

THC trades at a remarkably lean 9.43 P/E despite operating in healthcare services, suggesting either deep undervaluation or latent operational concerns. The stock sits comfortably in neutral territory at RSI 42.5—neither oversold nor overbought—with minimal short interest at 3.17% of float, indicating no imminent squeeze risk. Trading below its 52-week high amid a $17B market cap, this appears to reflect cautious market sentiment toward hospital operators rather than distress. The valuation gap versus healthcare peers warrants scrutiny into THC's margin trends and capital efficiency metrics before concluding it's a bargain.